Associations between use of the 21‐gene recurrence score assay and chemotherapy regimen selection in a statewide registry
Sign Up to like & getrecommendations! Published in 2017 at "Cancer"
DOI: 10.1002/cncr.30429
Abstract: The 21‐gene recurrence score (RS) assay predicts response to adjuvant chemotherapy in patients with early‐stage, hormone receptor‐positive, human epidermal growth factor receptor 2 (HER2)‐negative invasive breast cancer, but to the authors' knowledge, the role of… read more here.
Keywords: chemotherapy; chemotherapy regimen; gene recurrence; recurrence score ... See more keywords